1 ervention), the proportion of women who were amenorrheic at 6 mo was 64.5% in the SF group, 80.0% in

2                                              Amenorrheic athletes had significantly lower BMD (P < .0

3    Duration of amenorrhea and body weight of amenorrheic athletes predicted BMD at the femoral neck,

4 he predicted the BMD of the lumbar spine for amenorrheic athletes.

5 sing cardiovascular magnetic resonance in 13 amenorrheic DMPA users (>1 year use; mean age 29+/-4 yea

6                                      AN were amenorrheic; HC and OW/OB were studied in the follicular

7                     Athletes were defined as amenorrheic if they had had fewer than 2 menstrual cycle

8                      The only patient who is amenorrheic is currently receiving medroxyprogesterone a

9                                              Amenorrheic patients with hormone receptor-positive tumo

10                           Twenty-six healthy amenorrheic (peri- or postmenopausal) women not using ho

11                                 Twenty-seven amenorrheic women aged 26.6 +/- 1.2 y with anorexia nerv

12 The risk of OFR during treatment with AIs in amenorrheic women in their 40s is high, and AI therapy s